2024-04-012025-03-312025-03-31false10105035CONTEXT THERAPY LIMITED2025-04-28falseiso4217:GBPxbrli:pure101050352024-04-01101050352025-03-31101050352024-04-012025-03-31101050352023-04-01101050352024-03-31101050352023-04-012024-03-3110105035bus:SmallEntities2024-04-012025-03-3110105035bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110105035bus:FullAccounts2024-04-012025-03-3110105035bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110105035core:WithinOneYear2025-03-3110105035core:AfterOneYear2025-03-3110105035core:WithinOneYear2024-03-3110105035core:AfterOneYear2024-03-3110105035core:ShareCapital2025-03-3110105035core:SharePremium2025-03-3110105035core:RevaluationReserve2025-03-3110105035core:OtherReservesSubtotal2025-03-3110105035core:RetainedEarningsAccumulatedLosses2025-03-3110105035core:ShareCapital2024-03-3110105035core:SharePremium2024-03-3110105035core:RevaluationReserve2024-03-3110105035core:OtherReservesSubtotal2024-03-3110105035core:RetainedEarningsAccumulatedLosses2024-03-3110105035core:LandBuildings2025-03-3110105035core:PlantMachinery2025-03-3110105035core:Vehicles2025-03-3110105035core:FurnitureFittings2025-03-3110105035core:OfficeEquipment2025-03-3110105035core:NetGoodwill2025-03-3110105035core:IntangibleAssetsOtherThanGoodwill2025-03-3110105035core:ListedExchangeTraded2025-03-3110105035core:UnlistedNon-exchangeTraded2025-03-3110105035core:LandBuildings2024-03-3110105035core:PlantMachinery2024-03-3110105035core:Vehicles2024-03-3110105035core:FurnitureFittings2024-03-3110105035core:OfficeEquipment2024-03-3110105035core:NetGoodwill2024-03-3110105035core:IntangibleAssetsOtherThanGoodwill2024-03-3110105035core:ListedExchangeTraded2024-03-3110105035core:UnlistedNon-exchangeTraded2024-03-3110105035core:LandBuildings2024-04-012025-03-3110105035core:PlantMachinery2024-04-012025-03-3110105035core:Vehicles2024-04-012025-03-3110105035core:FurnitureFittings2024-04-012025-03-3110105035core:OfficeEquipment2024-04-012025-03-3110105035core:NetGoodwill2024-04-012025-03-3110105035core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110105035core:ListedExchangeTraded2024-04-012025-03-3110105035core:UnlistedNon-exchangeTraded2024-04-012025-03-3110105035core:MoreThanFiveYears2024-04-012025-03-3110105035core:Non-currentFinancialInstruments2025-03-3110105035core:Non-currentFinancialInstruments2024-03-3110105035dpl:CostSales2024-04-012025-03-3110105035dpl:DistributionCosts2024-04-012025-03-3110105035core:LandBuildings2024-04-012025-03-3110105035core:PlantMachinery2024-04-012025-03-3110105035core:Vehicles2024-04-012025-03-3110105035core:FurnitureFittings2024-04-012025-03-3110105035core:OfficeEquipment2024-04-012025-03-3110105035dpl:AdministrativeExpenses2024-04-012025-03-3110105035core:NetGoodwill2024-04-012025-03-3110105035core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110105035dpl:GroupUndertakings2024-04-012025-03-3110105035dpl:ParticipatingInterests2024-04-012025-03-3110105035dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110105035core:ListedExchangeTraded2024-04-012025-03-3110105035dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110105035core:UnlistedNon-exchangeTraded2024-04-012025-03-3110105035dpl:CostSales2023-04-012024-03-3110105035dpl:DistributionCosts2023-04-012024-03-3110105035core:LandBuildings2023-04-012024-03-3110105035core:PlantMachinery2023-04-012024-03-3110105035core:Vehicles2023-04-012024-03-3110105035core:FurnitureFittings2023-04-012024-03-3110105035core:OfficeEquipment2023-04-012024-03-3110105035dpl:AdministrativeExpenses2023-04-012024-03-3110105035core:NetGoodwill2023-04-012024-03-3110105035core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110105035dpl:GroupUndertakings2023-04-012024-03-3110105035dpl:ParticipatingInterests2023-04-012024-03-3110105035dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110105035core:ListedExchangeTraded2023-04-012024-03-3110105035dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110105035core:UnlistedNon-exchangeTraded2023-04-012024-03-3110105035core:NetGoodwill2025-03-3110105035core:IntangibleAssetsOtherThanGoodwill2025-03-3110105035core:LandBuildings2025-03-3110105035core:PlantMachinery2025-03-3110105035core:Vehicles2025-03-3110105035core:FurnitureFittings2025-03-3110105035core:OfficeEquipment2025-03-3110105035core:AfterOneYear2025-03-3110105035core:WithinOneYear2025-03-3110105035core:ListedExchangeTraded2025-03-3110105035core:UnlistedNon-exchangeTraded2025-03-3110105035core:ShareCapital2025-03-3110105035core:SharePremium2025-03-3110105035core:RevaluationReserve2025-03-3110105035core:OtherReservesSubtotal2025-03-3110105035core:RetainedEarningsAccumulatedLosses2025-03-3110105035core:NetGoodwill2024-03-3110105035core:IntangibleAssetsOtherThanGoodwill2024-03-3110105035core:LandBuildings2024-03-3110105035core:PlantMachinery2024-03-3110105035core:Vehicles2024-03-3110105035core:FurnitureFittings2024-03-3110105035core:OfficeEquipment2024-03-3110105035core:AfterOneYear2024-03-3110105035core:WithinOneYear2024-03-3110105035core:ListedExchangeTraded2024-03-3110105035core:UnlistedNon-exchangeTraded2024-03-3110105035core:ShareCapital2024-03-3110105035core:SharePremium2024-03-3110105035core:RevaluationReserve2024-03-3110105035core:OtherReservesSubtotal2024-03-3110105035core:RetainedEarningsAccumulatedLosses2024-03-3110105035core:NetGoodwill2023-04-0110105035core:IntangibleAssetsOtherThanGoodwill2023-04-0110105035core:LandBuildings2023-04-0110105035core:PlantMachinery2023-04-0110105035core:Vehicles2023-04-0110105035core:FurnitureFittings2023-04-0110105035core:OfficeEquipment2023-04-0110105035core:AfterOneYear2023-04-0110105035core:WithinOneYear2023-04-0110105035core:ListedExchangeTraded2023-04-0110105035core:UnlistedNon-exchangeTraded2023-04-0110105035core:ShareCapital2023-04-0110105035core:SharePremium2023-04-0110105035core:RevaluationReserve2023-04-0110105035core:OtherReservesSubtotal2023-04-0110105035core:RetainedEarningsAccumulatedLosses2023-04-0110105035core:AfterOneYear2024-04-012025-03-3110105035core:WithinOneYear2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110105035core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110105035core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110105035core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110105035core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110105035core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110105035bus:Director12024-04-012025-03-3110105035bus:Director22024-04-012025-03-3110105035core:FurnitureFittingsToolsEquipment2024-03-3110105035core:FurnitureFittingsToolsEquipment2024-04-012025-03-3110105035core:FurnitureFittingsToolsEquipment2025-03-31

CONTEXT THERAPY LIMITED

Registered Number
10105035
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

CONTEXT THERAPY LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr Carlton Coulter
Dr Sophie Coulter

Registered Address

42 High Street Wanstead
London
E11 2RJ

Registered Number

10105035 (England and Wales)
CONTEXT THERAPY LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets34,7207,080
Tangible assets42,0212,524
6,7419,604
Current assets
Debtors56,5708,270
Cash at bank and on hand86,30245,801
92,87254,071
Creditors amounts falling due within one year6(35,384)(27,737)
Net current assets (liabilities)57,48826,334
Total assets less current liabilities64,22935,938
Provisions for liabilities7(505)(480)
Net assets63,72435,458
Capital and reserves
Called up share capital300300
Profit and loss account63,42435,158
Shareholders' funds63,72435,458
The financial statements were approved and authorised for issue by the Board of Directors on 28 April 2025, and are signed on its behalf by:
Dr Carlton Coulter
Director
Registered Company No. 10105035
CONTEXT THERAPY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page. The company was incorporated on 05 April 2016 and commenced trading on 01 April 2022.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
The acquisition goodwill has been recognised at cost less any impairment losses and being amortised over its useful life of 5 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings4
Office Equipment3
2.Average number of employees

20252024
Average number of employees during the year11
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 2411,80011,800
At 31 March 2511,80011,800
Amortisation and impairment
At 01 April 244,7204,720
Charge for year2,3602,360
At 31 March 257,0807,080
Net book value
At 31 March 254,7204,720
At 31 March 247,0807,080
4.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 April 242,9557333,688
Additions-720720
At 31 March 252,9551,4534,408
Depreciation and impairment
At 01 April 247394251,164
Charge for year7394841,223
At 31 March 251,4789092,387
Net book value
At 31 March 251,4775442,021
At 31 March 242,2163082,524
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables2,0703,770
Other debtors4,5004,500
Total6,5708,270
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables36873
Amounts owed to related parties13,02211,790
Taxation and social security21,99415,874
Total35,38427,737
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)505480
Total505480